[SLN] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -1,037.89%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 12,415 5,479 244 0 16 770 0 -
PBT -45,856 -36,041 -22,870 -20,526 -3,775 -10,362 -9,429 30.13%
Tax -6,446 -3,494 -3,288 -2,115 -2,157 -1,922 -2,784 15.00%
NP -39,410 -32,547 -19,582 -18,411 -1,618 -8,440 -6,645 34.50%
Tax Rate - - - - - - - -
Total Cost 51,825 38,026 19,826 18,411 1,634 9,210 6,645 40.77%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -317.44 -594.03 -8,025.41 0.00 -10,112.50 -1,096.10 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -1.33 -1.19 -0.78 -0.79 -0.07 -0.36 -0.31 27.44%
EPS Diluted -1.33 -1.19 -0.78 -0.79 -0.07 -0.36 -0.31 27.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.